Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation-Reference-Cited by-同舟云学术

Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation

Published:2018-06-03 Issue:9 Volume:18 Page:2295-2304
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Ius Fabio¹,Verboom Murielle²,Sommer Wiebke¹³,Poyanmehr Reza¹,Knoefel Ann-Kathrin¹,Salman Jawad¹,Kuehn Christian¹,Avsar Murat¹,Siemeni Thierry¹,Erdfelder Caroline¹,Hallensleben Michael²,Boethig Dietmar¹,Schwerk Nicolaus⁴⁵,Mueller Carsten⁴⁵,Welte Tobias⁴³,Falk Christine⁶,Haverich Axel¹³,Tudorache Igor¹,Warnecke Gregor¹³

Affiliation:

1. Department of Cardiothoracic, Transplant, and Vascular Surgery; Hannover Medical School; Hannover Germany

2. Department of Transfusion; Medicine Hannover Medical School; Hannover Germany

3. German Center for Lung Research (DZL/BREATH); Hannover Germany

4. Department of Respiratory Medicine; Hannover Medical School; Hannover Germany

5. Department of Paediatrics; Hannover Medical School; Hannover Germany

6. Institute of Transplant Immunology; Hannover Medical School; Hannover Germany

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14912/fullpdf

Reference29 articles.

1. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation;Lobo;J Heart Lung Transplant,2013

2. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation;Smith;J Heart Lung Transplant,2014

3. Early-donor-specific antibodies in lung transplantation: risk factors and impact on survival;Ius;J Heart Lung Transplant,2014

4. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation;Safavi;J Heart Lung Transplant,2014

5. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation;Morrell;J Heart Lung Transplant,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-Mediated Rejection in Lung Transplantation: Diagnosis and Therapeutic Armamentarium in a 21st Century Perspective;Transplant International;2024-08-07

2. Oversizing lung allografts deteriorates outcomes in patients with pulmonary fibrosis;The Journal of Heart and Lung Transplantation;2024-07

3. Impact of Transient and Persistent Donor-Specific Antibodies in Lung Transplantation;Transplant International;2024-05-08

4. Clinical outcomes following cessation of parenteral immunoglobulin therapy following lung transplantation;The Journal of Heart and Lung Transplantation;2023-12

5. Lung transplantation despite preformed donor-specific antihuman leukocyte antigen antibodies: a 9-year single-center experience;American Journal of Transplantation;2023-11